LURASIDONE HYDROCHLORIDE (lurasidone hydrochloride) by Jubilant Therapeutics is unclear. Approved for depression. First approved in 2021.
Drug data last refreshed 21h ago
unclear. However, its efficacy in bipolar depression could be mediated through a combination of central dopamine D 2 and serotonin Type 2 (5HT2A) receptor antagonism.
Worked on LURASIDONE HYDROCHLORIDE at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.